Publication date: May 26, 2025
KIELTYKA GLADKOWSKI KG LEGAL, as a proud member of Life Science Cluster, took part in LieScience4EU Conference, devoted to life science of the future; technology, innovation and policy.
LifeScience4EU Conference 2025, held under the Polish Presidency of the Council of the European Union, brought together top experts to explore how biotechnology, digital health, and next-generation medical technologies can drive meaningful change. By aligning innovation with policy and regulation, the conference aimed to build a more resilient and competitive European healthcare sector.
Publication date: January 29, 2025
Handwritten notes of an extremely difficult piece by the creator – ballade number 4. Chopin’s last ballade. A mature artistic work from 1842!! With the use of this masterpiece such pianists as Olejniczak, Zimmerman, Blechacz and other Polish and foreign pianists won the Chopin Competition. The future WORLD AMBASSADORS OF FRYDERYK CHOPIN’S MUSIC will win!
This is a document of the final version of the piece! Rare documents on the antiquarian market in perfect condition for its age. No equivalent, because there were only (compared to other forms of music) four of Chopin’s ballades!
Publication date: April 29, 2025
KIELTYKA GLADKOWSKI KG LEGAL is proud to have contributed the Polish chapter for the Legal500 Data Protection and Cybersecurity Guide 2025. We have focused on practical aspects of new regulations currently being implemented in Poland within cybersecurity as well as personal and non-personal data and how new regulations will impact entrepreneurs in most crucial sectors like technology, payment services, healthcare, energy, e-commerce.
Publication date: April 28, 2025
The lawyers of KIELTYKA GLADKOWSKI KG LEGAL participated on 24 April 2025 in the meeting of the Life Science Cluster devoted to investing in life science companies from the perspective of investment funds. The case study was presented by the active investor supporting the development of innovative projects in the area of life science, specializing in investing in startups and young technology companies, especially those operating at the intersection of science, health and new technologies.